MUMBAI: Domestic equity markets fell more than 2 percent on Friday to its lowest in nearly 14 months, on weak global cues amid caution ahead of a key U.S. jobs report due later in the day.

The BSE Sensex and NSE Nifty closed 562.88 points and 167.95 points lower at 25,201.90 and 7,655.05, respectively.

In the 50-share Nifty index, BPCL, Coal India, Bharti Airtel and Lupin closed higher between 0.20 percent and 1.50 per cent. On the other hand, Vedanta, GAIL, Tata Power, Tata Steel and Hindalco fell between 4 percent and 5 percent.

Among the sectoral indices on the Bombay Stock Exchange (BSE), the BSE Realty index tumbled the most 3.32 percent at 1,242.32, it was followed by the BSE Power index (down 3.03 percent), BSE Bankex (down 2.65 percent), BSE Healthcare index (down 2.42 percent) and BSE Information Technology index (down 2.34 percent). Rest all other sectoral indices on BSE ended in red.

Gaurav Jain, director, Hem Securities, said, “Strong carnage on the Indian benchmarks in line with its global partners. Continued selling pressure by the foreign portfolio investors, weakness in rupee and global jitters weighed on the sentiment.”

Market breadth for the day remained negative as advances to declines ratio for Nifty stood at 4:46 for the day.

Cipla fell 1.13 percent at Rs 649.40. The pharma major on Friday announced acquisition of two U.S.based pharma companies for total cash consideration of $550 million.

Lupin dropped 0.21 percent at Rs 1,859.25. Lupin’s U.S. subsidiary Lupin Pharmaceuticals, Inc. (Lupin) has launched a generic antidepressant medicine Duloxetine 40 mg Delayed-Release (DR) Capsule in the United States.

Glenmark Pharmaceuticals slid 3.63 percent at Rs 1,028.05. The company’s U.S. subsidiary Glenmark Pharmaceuticals Inc., U.S.A (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Voriconazole Tablets, 50 mg and 200 mg, the therapeutic equivalent of Vfend Tablets, 50 mg and 200 mg of PF Prism C.V. (Prism). Glenmark Pharmaceuticals made the announcement before market hours on Friday.

World shares slid towards their fourth weekly loss in the last five on Friday, as a boost from a supportive-sounding European Central Bank gave way to caution ahead of closely watched U.S. jobs data.